dr paul molyneux - managing pml risk in patients treated with natalizumab.
Published 4 years ago • 417 plays • Length 42:10Download video MP4
Download video MP3
Similar videos
-
41:36
dr david rog - pml in ms
-
37:00
professor david clifford - 'pml and multiple sclerosis'
-
8:18
risk analysis of natalizumab in progressive multifocal leukoencephalopathy
-
30:09
managing pml in the multiple sclerosis patient
-
6:16
tysabri: pml risk thought experiment
-
6:27
evaluating natalizumab’s risk-benefit profile in ms
-
35:05
webinar: what is pml?
-
5:42
risk of progressive multifocal leukoencephalopathy in oral therapies for multiple sclerosis
-
7:03
ms and tysabri related pml: the real facts
-
31:15
pml in the biologic era
-
58:44
progressive multifocal leukoencephalopathy
-
24:43
multiple myeloma update: frontline therapy
-
57:50
managing peripheral neuropathy 2017
-
5:03
the evaluation of pml lesions using mri in patients with multiple sclerosis
-
5:55
finding the right treatment for pml
-
17:24
aan 2016 - clinical trials on lipoic acid in multiple sclerosis
-
28:35
update on pml
-
1:21:21
progressive multifocal leukoencephalopathy in monoclonal antibodies era - joe berger - 5 april 2020